Anteris Technologies Ltd (AVR.AX)
AUD 5.15
(-2.83%)
AUD 5.15
(-2.83%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -66.9 Million AUD | -50.92% |
| 2022 | -43.03 Million AUD | -110.79% |
| 2021 | -21.42 Million AUD | -21.89% |
| 2020 | -15.64 Million AUD | 26.26% |
| 2019 | -4.05 Million AUD | -8.37% |
| 2018 | -22.22 Million AUD | -39.91% |
| 2017 | -15.88 Million AUD | -39.44% |
| 2016 | -14.06 Million AUD | 59.02% |
| 2015 | -27.8 Million AUD | -20.65% |
| 2014 | -22.87 Million AUD | -77.3% |
| 2013 | -13.17 Million AUD | -225.28% |
| 2012 | -4.15 Million AUD | -282.26% |
| 2011 | -3.64 Million AUD | 160.5% |
| 2010 | -727.58 Thousand AUD | 157.73% |
| 2009 | -1.44 Million AUD | -16.1% |
| 2008 | -1.25 Million AUD | 1.69% |
| 2007 | -1.48 Million AUD | -373.65% |
| 2006 | -2.78 Million AUD | 68.67% |
| 2005 | -860.85 Thousand AUD | -495.98% |
| 2004 | -1.88 Million AUD | 130.56% |
| 2003 | -639.45 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -53.72 Million AUD | 0.0% |
| 2023 Q4 | -39.11 Million AUD | 0.0% |
| 2023 Q2 | -29.77 Million AUD | 0.0% |
| 2023 FY | - AUD | -50.92% |
| 2022 Q4 | -23.71 Million AUD | 0.0% |
| 2022 Q2 | -21.93 Million AUD | 0.0% |
| 2022 FY | - AUD | -110.79% |
| 2021 FY | - AUD | -21.89% |
| 2021 Q2 | -9.2 Million AUD | 0.0% |
| 2021 Q4 | -12.45 Million AUD | 0.0% |
| 2020 Q2 | -9.5 Million AUD | 0.0% |
| 2020 Q4 | -8.25 Million AUD | 0.0% |
| 2020 FY | - AUD | 26.26% |
| 2019 Q2 | -12.57 Million AUD | 0.0% |
| 2019 Q4 | -12.29 Million AUD | 0.0% |
| 2019 FY | - AUD | -8.37% |
| 2018 Q4 | -11.74 Million AUD | 0.0% |
| 2018 FY | - AUD | -39.91% |
| 2018 Q2 | -10.48 Million AUD | 0.0% |
| 2017 FY | - AUD | -39.44% |
| 2017 Q2 | -8.12 Million AUD | 0.0% |
| 2016 Q2 | -12.65 Million AUD | 0.0% |
| 2016 Q4 | -6.03 Million AUD | 0.0% |
| 2016 FY | - AUD | 59.02% |
| 2015 Q4 | -15.15 Million AUD | 0.0% |
| 2015 FY | - AUD | -20.65% |
| 2015 Q2 | -12.52 Million AUD | 0.0% |
| 2014 FY | - AUD | -77.3% |
| 2014 Q2 | -9.49 Million AUD | 0.0% |
| 2014 Q4 | -10.52 Million AUD | 0.0% |
| 2013 FY | - AUD | -225.28% |
| 2013 Q4 | -3.68 Million AUD | 0.0% |
| 2013 Q2 | -2.7 Million AUD | 0.0% |
| 2012 Q2 | -2.46 Million AUD | 0.0% |
| 2012 Q1 | -2.46 Million AUD | 0.0% |
| 2012 FY | - AUD | -282.26% |
| 2012 Q4 | -1.45 Million AUD | 41.13% |
| 2012 Q3 | -2.46 Million AUD | 0.0% |
| 2011 Q2 | -483.68 Thousand AUD | 0.0% |
| 2011 Q3 | -483.68 Thousand AUD | 0.0% |
| 2011 Q4 | -2.46 Million AUD | -409.38% |
| 2011 FY | - AUD | 160.5% |
| 2011 Q1 | -483.68 Thousand AUD | 0.0% |
| 2010 FY | - AUD | 157.73% |
| 2010 Q3 | -325.61 Thousand AUD | 0.0% |
| 2010 Q4 | -483.68 Thousand AUD | -48.55% |
| 2010 Q2 | -325.61 Thousand AUD | 0.0% |
| 2010 Q1 | -325.61 Thousand AUD | 0.0% |
| 2009 Q3 | -292.85 Thousand AUD | 0.0% |
| 2009 Q4 | -325.61 Thousand AUD | -11.18% |
| 2009 Q2 | -292.85 Thousand AUD | 0.0% |
| 2009 FY | - AUD | -16.1% |
| 2009 Q1 | -292.85 Thousand AUD | 0.0% |
| 2008 Q3 | -333.28 Thousand AUD | 0.0% |
| 2008 FY | - AUD | 1.69% |
| 2008 Q4 | -292.85 Thousand AUD | 12.13% |
| 2008 Q2 | -333.28 Thousand AUD | 0.0% |
| 2008 Q1 | -333.28 Thousand AUD | 0.0% |
| 2007 Q1 | -659.67 Thousand AUD | 0.0% |
| 2007 Q4 | -333.28 Thousand AUD | 49.48% |
| 2007 FY | - AUD | -373.65% |
| 2007 Q3 | -659.67 Thousand AUD | 0.0% |
| 2007 Q2 | -659.67 Thousand AUD | 0.0% |
| 2006 Q3 | -275.07 Thousand AUD | 0.0% |
| 2006 Q4 | -659.67 Thousand AUD | -139.82% |
| 2006 FY | - AUD | 68.67% |
| 2006 Q1 | -275.07 Thousand AUD | 0.0% |
| 2006 Q2 | -275.07 Thousand AUD | 0.0% |
| 2005 Q4 | -275.07 Thousand AUD | 68.79% |
| 2005 FY | - AUD | -495.98% |
| 2005 Q1 | -881.4 Thousand AUD | 0.0% |
| 2005 Q2 | -881.4 Thousand AUD | 0.0% |
| 2005 Q3 | -881.4 Thousand AUD | 0.0% |
| 2004 Q3 | -177.81 Thousand AUD | 0.0% |
| 2004 FY | - AUD | 130.56% |
| 2004 Q2 | -177.81 Thousand AUD | 0.0% |
| 2004 Q4 | -881.4 Thousand AUD | -395.68% |
| 2004 Q1 | -177.81 Thousand AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2003 Q4 | -177.81 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | -85.501% |
| Adherium Limited | -11.56 Million AUD | -478.533% |
| Aroa Biosurgery Limited | -7.36 Million AUD | -809.015% |
| Atomo Diagnostics Limited | -5.42 Million AUD | -1133.601% |
| Control Bionics Limited | -5.15 Million AUD | -1197.045% |
| CardieX Limited | -6.71 Million AUD | -896.808% |
| Compumedics Limited | 2.78 Million AUD | 2498.862% |
| Cochlear Limited | 579.5 Million AUD | 111.545% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -1816.037% |
| Cyclopharm Limited | -3.03 Million AUD | -2104.496% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -3099.311% |
| Nova Eye Medical Limited | -5.97 Million AUD | -1018.987% |
| HeraMED Limited | -3.97 Million AUD | -1584.371% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | -205.912% |
| ImpediMed Limited | -22.05 Million AUD | -203.407% |
| InhaleRx Limited | -1.41 Million AUD | -4632.42% |
| LBT Innovations Limited | -4.04 Million AUD | -1552.365% |
| Micro-X Limited | -14.35 Million AUD | -366.199% |
| Neurotech International Limited | -8.24 Million AUD | -711.548% |
| OncoSil Medical Limited | -11.97 Million AUD | -458.645% |
| PolyNovo Limited | 5.17 Million AUD | 1394.086% |
| Respiri Limited | -7.04 Million AUD | -849.009% |
| SomnoMed Limited | -2.32 Million AUD | -2773.138% |
| Universal Biosensors, Inc. | -9.09 Million AUD | -635.985% |
| Uscom Limited | -1.5 Million AUD | -4332.771% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -1260.563% |